Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Phase II Trial of Temozolomide in Elderly Patients With Glioblastoma and Poor Performance Status (KPS<70).

Authors not listed

Assistance Publique - Hôpitaux de Paris · 2007

Abstract

The management of glioblastoma in elderly patients with poor performance status (KPS\<70) is unsettled. This single arm phase 2 trial trial was designed to evaluate the efficacy and safety of temozolomide alone in this population

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Anonymous. (2007). Phase II Trial of Temozolomide in Elderly Patients With Glioblastoma and Poor Performance Status (KPS<70). <em>Assistance Publique - Hôpitaux de Paris</em>. https://clinicaltrials.gov/study/NCT01242566
Vancouver
Anonymous. Phase II Trial of Temozolomide in Elderly Patients With Glioblastoma and Poor Performance Status (KPS<70). Assistance Publique - Hôpitaux de Paris. 2007.
BibTeX
@misc{anon2007PhaseI, title = {Phase II Trial of Temozolomide in Elderly Patients With Glioblastoma and Poor Performance Status (KPS<70).}, author = {Anonymous}, journal = {Assistance Publique - Hôpitaux de Paris}, year = {2007}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings